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Abstract
Primary chest wall tumors are uncommon and constitute 0.2-2% of all tumors. Metastatic tumors and tumors of local 
extension are more common. Malignant peripheral nerve sheath tumor (MPNST) of the chest wall is even rarer and its 
incidence on the chest wall not stated in the literature. The incidence in the general population is 0.0001% while the 
risk is approximately 4600 times higher in patients with type I neurofibromatosis and 3-13% of them will finally develop 
into MPNST, usually after latent periods of 10-20 years. Clinically, these tumors are aggressive, locally invasive, and 
highly metastatic. Excision of giant chest wall tumor leaves a defect that is reconstructed using musculocutaneous flaps 
with or without a mesh. We report the case of a 24-year-old man who presented at the surgical outpatient clinic with 7 
months history of persistent left sided chest pain minimally relieved by analgesics, 5 months of cough and worsening 
dyspnoea, and 3 months history of anterior chest swelling on the left side of the manubrium. Following evaluation and 
investigations, the tumor was excised and the residual defect closed with methylmetacrylate sandwiched between two 
prolene meshes and overlaid with both pectoralis major muscles. The histology of the excised mass revealed MPNST 
He made an uneventful postoperative recovery, but died barely 3 months later from widespread pulmonary metastases. 
A review of the literature revealed that such tumors hardly ever reach such large-size as in our case.
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Introduction
Primary chest wall tumors are uncommon and constitute 
0.2-2% of all tumors.[1] Metastatic tumors and tumors of 
local extension are more common. The actual incidence of 
malignant peripheral nerve sheath tumor (MPNST) of the 
chest wall is not stated in the literature, but the incidence in 
the general population is 0.0001%.[2] The risk is approximately 
4600 times higher in patients with type I neurofibromatosis 
and 3-13% of them will finally develop MPNST, usually 
after latent periods of 10-20 years.[2] This tumor previously 
known as malignant schwannoma, neurogenic sarcoma, 
and neurofibrosarcoma arise from embryonic neural crest 
cells, which normally constitute ganglia, paraganglionic, 
and parasympathetic systems. Clinically, these tumors are 
aggressive, locally invasive, and highly metastatic.[3] Excision 
of giant chest wall tumor leaves a defect that is reconstructed 
using musculocutaneous flaps with or without a mesh. A 
review of the literature revealed that such tumors hardly ever 
reach such large-size as in our case.
Case Report
Our patient was a 24-year-old man who presented at the 
surgical outpatient clinic with 7 months history of persistent 
left sided chest pain minimally relieved by analgesics and, 
which greatly interfered with his sleep. He also presented with 
5 months history of cough and worsening dyspnoea and 3 
months history of anterior chest swelling on the left side of the 
manubrium. There was no preceding history of trauma, fever, 
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drenching night sweats, contact with a patient with chronic 
cough, hemoptysis, orthopnoea, and paroxysmal nocturnal 
dyspnoea or body swellings. He had no significant premorbid 
medical history. At initial presentation, he had a performance 
score of 90% (Karnofsky). The essential finding was that of a 
manubrial lump more to the left with normal overlying skin 
[Figure 1]. It was neither tender nor warm and was hard in 
consistency. It measured 8 cm × 12 cm in widest dimensions. 
The regional and other peripheral lymph nodes were not 
enlarged. The intensity of the breath sound was only slightly 
diminished on the left side. An initial impression of a chest 
wall tumor possibly a chondrosarcoma was entertained. Having 
visited several hospitals, he came with a chest X-ray which 
showed a large radio-opaque mass in the anterio-superior 
mediastinum. It took him 2 months to get a chest computed 
tomography scan [Figure 2] and another 4 months to get money 
for surgery by which time the tumor was exceedingly large and 
he was now dyspnoeic at rest. Because an initial Tru-cut needle 
biopsy was not representative, we decided to go ahead with 
surgical excision. At surgery, Via a T-shaped sternal incision 
[Figure 6] the tumor was found to have invaded the whole of 
the upper third of the manubrio-sternum and having a dumb-
bell shape. The outer and smaller portion (manubriosternal) 
measured 8 cm × 12 cm × 14 cm while the larger half wholly 
intrathoracic portion (left side) measured 18 cm × 24 cm × 
30 cm in widest dimensions and weighing 5.4 kg [Figure 3]. 
The tumor was excised in continuum with the medial ends 
of the clavicles, the upper half of the manubrio-sternum and 
the upper four costal cartilages. Total left parietal and visceral 
pleurectomy was achieved. The pericardium was not invaded 
and mediastinal lymph nodes were not enlarged. The excision 
was thought to be complete as no macroscopic tumor was left 
behind. The anterior sternal defect created was covered with 
methylmetacrylate sandwiched between two 15 cm × 15 cm 
prolene meshes [Figure 4]. Both pectoralis major muscles were 
mobilized and used to cover the methylmetacrylate/prolene 
sandwich. He made an uneventful recovery postoperatively. 
The histology report revealed MPNST with incomplete 
resection margin [Figure 5]. He was discharged 2 weeks after 
surgery, was seen in the outpatient clinic 2 weeks thereafter 
discharge. By the second visit which was 8 weeks after surgery 
he had a recurrence at the right root of the neck. The chest 
X-ray then revealed widespread pulmonary metastases. He was 
readmitted 2 weeks later, barely 3 months postoperative and 
died within 4 days of readmission.
Discussion
The treatment of large chest wall tumors was limited for many 
years until 1898 when Parham described the first thoracic 
resection of a chest neoplasm.[4] Initially, the risks of surgery 
were related to pneumothorax and respiratory failures.[5] 
Advances in anesthesia and controlled airway ventilation 
with positive pressure allowed chest wall resections to be 
done safely. Early attempts at reconstruction included the use 
of fascia lata and rib grafts.[6] As early as 1960, Graham and 
Usher introduced the use of prosthetic materials when they 
described the use of marlex mesh to repair defects of the chest 
wall.[5] A combination of prosthetic materials and rotational 
Figure 1: Preoperative view showing tumor penetrating the chest 
wall (manubrio-sternum)
Figure 2: Computed tomography scanogram of chest showing 
tumor occupying most of the left hemithorax
Figure 3: Excised tumor measuring 18 cm × 24 cm × 30 cm
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flaps, with improvement in mechanical ventilation provide 
good cosmetic and functional results and short hospital stays. 
Latissimus dorsi myocutaneous flap is the most used method 
for extensive soft-tissue defects in chest wall reconstruction, 
but it is best suited for lateral defects.[5] For our patient, we 
used both pectoralis muscles because of their proximity to 
the midline.[7] Chest wall reconstruction in our environment 
is a challenge because of late presentation as in our patient. 
Other challenges include availability of the prostheses (mesh 
and methylmetacrylate). The methylmetacrylate restores the 
rigidity of the chest wall while the mesh provides a scaffold for 
fibrous tissue infiltration during healing. Another challenge 
is affordability of these prostheses even where there is the 
expertise; this featured prominently in this patient as it took 
him over 6 months to source funds for his surgery (enough time 
for the tumor to more than double in size and metastasize). The 
sum of these challenges serves to limit the amount of work done 
by thoracic surgeons and therefore, the availability of literature 
in this regard (particularly in our locality). To achieve a cure as 
much as possible, about 5 cm (King et al had recommended 4 
cm for aggressive tumors)[8] margin was given during resection 
of the tumor. Total left parietal pleurectomy (as the tumor was 
adhered to the upper lateral and anterior left parietal pleura), 
and bilateral medial third claviculectomy was performed. This 
unfortunately proved to be inadequate because the tumor 
disseminates hematogenously like most sarcomas. Therefore, 
while the patient had an excellent postoperative recovery, he 
died barely 3 months later.
Conclusion
Chest wall reconstruction poses a formidable challenge in 
our environment due to late presentation and therefore, 
very advance diseases. Affordability and availability of the 
prostheses also serve to limit the extent of work done by 
even the very experienced thoracic surgeons.
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Figure 4: Both pectoralis major muscles been sewn together over 
the sandwiched mesh (white with blue stripes)
Figure 6: Patient sitting up on bed in intensive care unit 
postoperative revealing T-shaped incision  used to excise tumor
Figure 5: Excised tumor measuring 18 cm × 24 cm × 30 cm 
Hematoxyline and Eosin (x 400). Sections show fascicles of 
spindle	cell	with	serpentine	dark	nuclei,	fibrillary	cytoplasm	
and	mitotic	figures.The	tumour	is	collagen	rich	on	special	stain	
(Mason’s Trichrome)
